Trimethylamine-N-oxide is an important target for heart and brain diseases.

Shusi Ding,Jing Xue,Qi Zhang,Lemin Zheng
DOI: https://doi.org/10.1515/mr-2022-0026
2022-01-01
Abstract:Trimethylamine-N-oxide (TMAO) is a metabolite produced from dietary nutrients by the gut microbiome, which was first discovered in 2011 and used to predict the risk of car-diovascular disease [1].
What problem does this paper attempt to address?